SCHEMBL30953063

SCHEMBL30953063

CC1CCC([C@H](NC(=O)OC(C)(C)C)C(=O)Nc2cc(C(NC(=O)CCC(F)(F)F)C3CC3)ccn2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 9/20 0.42
▸ RAB9A P51151 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ SCN9A Q15858 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ USP30 Q70CQ3 1/20 0.31
▸ MMP1 P03956 1/20 0.31
▸ PSEN1 P49768 1/20 0.30
▸ PSEN2 P49810 1/20 0.30
▸ APH1B Q8WW43 1/20 0.30
▸ NCSTN Q92542 1/20 0.30
▸ APH1A Q96BI3 1/20 0.30
▸ PSENEN Q9NZ42 1/20 0.30
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953125 0.91 AAK1 (0.41) AAK1RAB9AMEN1NPC1TP53
SCHEMBL30953539 0.88 IGF1R (0.36) AAK1RAB9AMEN1NPC1TP53
SCHEMBL30953247 0.87 AAK1 (0.35) AAK1RAB9AMEN1NPC1TP53
SCHEMBL30953361 0.85 RAB9A (0.35) RAB9ALMNAMEN1NPC1TP53
SCHEMBL30953100 0.83 GSK3B (0.36) RAB9ANPC1KMT2ASMN1; SMN2USP30
SCHEMBL30953381 0.82 AAK1 (0.46) AAK1RAB9ALMNASCN9AMMP1
SCHEMBL30952985 0.82 IL17A (0.36) —
SCHEMBL30953307 0.81 AAK1 (0.45) AAK1RAB9ALMNACYP3A4MMP1
SCHEMBL30953440 0.80 AAK1 (0.51) AAK1RAB9ALMNAMMP1
SCHEMBL30953221 0.79 AAK1 (0.48) AAK1RAB9ALMNAKMT2ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP claimed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO claimed
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback